World's Best Scientists 2026 revealed!

D-Index & Metrics

Molecular Biology

D-Index
103
Citations
29251
World Ranking
482
National Ranking
36

Medicine

D-Index
104
Citations
30416
World Ranking
7134
National Ranking
697

Nicholas R. Lemoine publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Nicholas R. Lemoine sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 353 publications — 87th percentile

87% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Nicholas R. Lemoine D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Nicholas R. Lemoine sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 103 D-Index — 85th percentile

85% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Overview

Nicholas R. Lemoine is affiliated with Queen Mary University of London in the United Kingdom. Their research primarily spans the fields of biochemistry, genetics, molecular biology, and medicine, with particular focus on oncology, genetics, immunology, molecular biology, and biotechnology.

Their work concentrates on major topics including CAR-T cell therapy research, virus-based gene therapy research, cancer research and treatments, immunotherapy and immune responses, cancer immunotherapy and biomarkers, immune cell function and interaction, and RNA and protein synthesis mechanisms.

Publications by Nicholas R. Lemoine have appeared frequently in several scientific journals. Notable publication venues include:

  • Frontiers in Immunology (7 publications)
  • Journal for ImmunoTherapy of Cancer (4 publications)
  • Molecular Therapy - Oncolytics (3 publications)
  • Pancreatology (3 publications)
  • Clinical Cancer Research (2 publications)

Some recent papers authored by or involving Lemoine include:

  • SNPnexus: a web server for functional annotation of human genome sequence variation (2020), Nucleic Acids Research
  • CEACAM7 Is an Effective Target for CAR T-cell Therapy of Pancreatic Ductal Adenocarcinoma (2021), Clinical Cancer Research
  • A new oncolytic V accinia virus augments antitumor immune responses to prevent tumor recurrence and metastasis after surgery (2020), Journal for ImmunoTherapy of Cancer
  • Transient Inhibition of PI3Kδ Enhances the Therapeutic Effect of Intravenous Delivery of Oncolytic Vaccinia Virus (2020), Molecular Therapy
  • Oncolytic vaccinia virus and cancer immunotherapy (2024), Frontiers in Immunology

Lemoine has collaborated extensively with several co-authors, including:

  • Yaohe Wang (29 co-authored works)
  • Louisa S. Chard (20 co-authored works)
  • Zhongxian Zhang (10 co-authored works)
  • Shuangshuang Lu (10 co-authored works)
  • Zhenguo Cheng (9 co-authored works)

In addition to articles, Lemoine has contributed to book publications, including the title "Gene Therapy" (2020) published by Garland Science eBooks.

Best Publications

  • Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: the fragmin advanced malignancy outcome study (FAMOUS).

    Ajay K. Kakkar;Mark N. Levine;Zbigniew Kadziola;Nicholas R. Lemoine

  • The serine protease Omi/HtrA2 regulates apoptosis by binding XIAP through a Reaper-like motif

    L. Miguel Martins;Ingram Iaccarino;Tencho Tenev;Stephen Gschmeissner

  • The type 1 (EGFR-related) family of growth factor receptors and their ligands.

    Sally A. Prigent;Nicholas R. Lemoine

  • High frequency of ras oncogene activation in all stages of human thyroid tumorigenesis.

    N R Lemoine;E S Mayall;F S Wyllie;E D Williams

  • Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of K-ras, p53, p16 and DPC4/Smad4.

    Patrick S. Moore;Bence Sipos;Simonetta Orlandini;Claudio Sorio

  • Arginine deprivation and argininosuccinate synthetase expression in the treatment of cancer.

    Barbara Delage;Dean A. Fennell;Linda Nicholson;Iain McNeish;Iain McNeish

  • The ubiquitin-proteasome pathway regulates survivin degradation in a cell cycle-dependent manner

    Jian Zhao;Tencho Tenev;Luis M. Martins;Julian Downward

  • Identification of Novel Isoforms of the BH3 Domain Protein Bim Which Directly Activate Bax To Trigger Apoptosis

    Michela Marani;Tencho Tenev;David Hancock;Julian Downward

  • Yes-associated protein (YAP) functions as a tumor suppressor in breast.

    M Yuan;V Tomlinson;R Lara;D Holliday

  • Expression of the Met/Hepatocyte Growth Factor Receptor in Human Pancreatic Cancer

    M. F. Di Renzo;R. Poulsom;M. Olivero;P. M. Comoglio

  • Cancer gene therapy: hard lessons and new courses.

    R G Vile;S J Russell;N R Lemoine

  • Periostin promotes invasiveness and resistance of pancreatic cancer cells to hypoxia-induced cell death: role of the beta4 integrin and the PI3k pathway.

    P Baril;R Gangeswaran;P C Mahon;K Caulee

  • The use of DNA viruses as vectors for gene therapy.

    M. Ali;N. R. Lemoine;Christopher J. Ring

  • Activated ras oncogenes in human thyroid cancers.

    Lemoine Nr;Mayall Es;Wyllie Fs;Farr Cj

  • Loss of membranous E-cadherin expression in pancreatic cancer: correlation with lymph node metastasis, high grade, and advanced stage.

    Massimo Pignatelli;Tareq W. Ansari;Pat Gunter;Dan Liu

  • Proliferative index in breast carcinoma determined in situ by Ki67 immunostaining and its relationship to clinical and pathological variables

    Nicola J. Barnard;P. A. Hall;N. R. Lemoine;N. Kadar

  • Transforming growth factor alpha and epidermal growth factor in human pancreatic cancer.

    Claire M. Barton;Peter A. Hall;Peter A. Hall;Christine M. Hughes;William J. Gullick

  • Characterization of Gene Expression Profiles in Intraductal Papillary-Mucinous Tumors of the Pancreas

    Benoit Terris;Ekaterina Blaveri;Tatjana Crnogorac-Jurcevic;Melanie Jones

  • Pancreatic cancer: molecular pathogenesis and new therapeutic targets

    Han H. Wong;Nicholas R. Lemoine

  • Pancreatic tumours: molecular pathways implicated in ductal cancer are involved in ampullary but not in exocrine nonductal or endocrine tumorigenesis.

    P Moore;S Orlandini;Giorgio Zamboni;P Capelli

Frequent Co-Authors

Iain A. McNeish
Iain A. McNeish Imperial College London
John P. Neoptolemos
John P. Neoptolemos Heidelberg University
William J. Gullick
William J. Gullick University of Kent
Aldo Scarpa
Aldo Scarpa University of Verona
David Kirn
David Kirn University of California, Berkeley
Massimo Falconi
Massimo Falconi Vita-Salute San Raffaele University
Claudio Bassi
Claudio Bassi University of Verona
Giuseppe Zamboni
Giuseppe Zamboni University of Verona
Thomas M. Gress
Thomas M. Gress Philipp University of Marburg
Julian Downward
Julian Downward The Francis Crick Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in molecular biology, exploring related online degrees can open up a wide array of career opportunities. Interdisciplinary skills are highly valued in the sciences, and pursuing an online interdisciplinary studies degree career outcomes may lead to roles in research, education, health, policy, or biotech industries.

Creativity and data presentation are essential in scientific fields. By enrolling in online graphic design courses, students can gain valuable skills for effectively communicating complex information through visual media such as scientific posters or digital platforms.

Those who wish to integrate historical perspectives into their scientific research can consider the cheapest online history master's degree. This can be especially useful for focusing on the history of science or ethics in biomedical research.

For students interested in organizing, accessing, and sharing scientific information, obtaining the cheapest masters in library science can lead to careers in academic libraries, information management, or knowledge curation.

Best Scientists Citing Nicholas R. Lemoine

Trending Scientists

Recently Published Articles